Barclays Slashes Ralliant Price Target to $52 After ‘Thesis-Changing’ Quarter
On February 9 Barclays cut Ralliant’s price target to $52 from $60, maintaining an Overweight rating after labeling its quarter “thesis-changing.” Earlier this month Morgan Stanley and Truist trimmed targets to $45 and $49, citing Ralliant’s $555M Q4 revenue, a one-time charge and operating expenses that reset the 2026 outlook.
1. Analyst Price Target Revisions
On February 9 Barclays lowered its price target on Ralliant to $52 from $60 while maintaining an Overweight rating, describing the latest quarter as “thesis-changing.” Earlier in February, Morgan Stanley cut its target to $45 from $55 with an Overweight stance and Truist trimmed its target to $49 from $62, both citing reset expectations after the quarter.
2. Quarterly Revenue Beat & Growth
Ralliant reported Q4 revenue of $555 million versus consensus of $545.4 million, marking its third consecutive quarter of sequential revenue growth. President and CEO Tami Newcombe highlighted disciplined execution and results at or above the high end of guidance.
3. One-Time Charge and Expense Impact
Truist noted a sizable one-time charge and elevated operating expenses weighed on results, prompting a reset of 2026 estimates. Higher costs in the quarter have analysts modeling more conservative margin projections for the year ahead.
4. Business Segments and Market Exposure
Ralliant operates through Test and Measurement and Sensors and Safety Systems segments, serving precision instrument markets in the U.S., China, Western Europe and other international regions. The diversified end markets and mid-single-digit organic growth underpin analysts’ long-term outlooks despite near-term headwinds.